Cargando…

How VEGF-A and its splice variants affect breast cancer development – clinical implications

BACKGROUND: Altered expression levels and structural variations in the vascular endothelial growth factor (VEGF) have been found to play important roles in cancer development and to be associated with the overall survival and therapy response of cancer patients. Particularly VEGF-A and its splice va...

Descripción completa

Detalles Bibliográficos
Autores principales:	Al Kawas, Hivin, Saaid, Inas, Jank, Paul, Westhoff, Christina C., Denkert, Carsten, Pross, Therese, Weiler, Karoline Barbara Stephanie, Karsten, Maria Margarete
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Netherlands 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9050780/ https://www.ncbi.nlm.nih.gov/pubmed/35303290 http://dx.doi.org/10.1007/s13402-022-00665-w

Ejemplares similares

Role of Routine Peritoneal Biopsies During Risk Reducing Salpingo-Oophorectomy (RRSO)
por: Pross, Therese, et al.
Publicado: (2021)

VEGF Spliced Variants: Possible Role of Anti-Angiogenesis Therapy
por: Hilmi, Caroline, et al.
Publicado: (2012)

VEGF-A splice variants bind VEGFRs with differential affinities
por: Mamer, Spencer B., et al.
Publicado: (2020)

Examining the Feasibility of an Application-Based Patient-Reported Outcome Monitoring for Breast Cancer Patients: A Pretest for the PRO B Study
por: Hage, Anna Maria, et al.
Publicado: (2022)

VEGF-A165b levels are reduced in breast cancer patients at primary diagnosis but increase after completion of cancer treatment
por: Karsten, Maria Margarete, et al.
Publicado: (2020)

VEGF111b, a C-terminal splice variant of VEGF-A and induced by mitomycin C, inhibits ovarian cancer growth
por: Li, Xiuli, et al.
Publicado: (2015)

A group of novel VEGF splice variants as alternative therapeutic targets in renal cell carcinoma
por: Montemagno, Christopher, et al.
Publicado: (2023)

MutPred Splice: machine learning-based prediction of exonic variants that disrupt splicing
por: Mort, Matthew, et al.
Publicado: (2014)

Role of alternative splicing of VEGF-A in the development of atherosclerosis
por: Zhao, Naishi, et al.
Publicado: (2018)

What turns CREB on? And off? And why does it matter?
por: Steven, André, et al.
Publicado: (2020)

How Was Nature Able to Discover Its Own Laws—Twice?
por: Pross, Addy
Publicado: (2021)

Microenvironment Changes (in pH) Affect VEGF Alternative Splicing
por: Elias, Ana Paula, et al.
Publicado: (2008)

Retraction: Role of alternative splicing of VEGF-A in the development of atherosclerosis
por: Zhao, Naishi, et al.
Publicado: (2023)

The splicing factor YBX1 promotes the progression of osteosarcoma by upregulating VEGF(165) and downregulating VEGF(165b)
por: Quan, Bingxuan, et al.
Publicado: (2023)

HTLV-I antisense transcripts initiating in the 3'LTR are alternatively spliced and polyadenylated
por: Cavanagh, Marie-Hélène, et al.
Publicado: (2006)

VEGF(121)b, a new member of the VEGF(xxx)b family of VEGF-A splice isoforms, inhibits neovascularisation and tumour growth in vivo
por: Rennel, E S, et al.
Publicado: (2009)

Protein-Protein Interaction Inhibitor of SRPKs Alters the Splicing Isoforms of VEGF and Inhibits Angiogenesis
por: Li, Qingyun, et al.
Publicado: (2021)

Nodal lymphangiogenesis and immunophenotypic variations of sinus endothelium in sentinel and non-sentinel lymph nodes of invasive breast carcinoma
por: Westhoff, Christina C., et al.
Publicado: (2023)

How and why kinetics, thermodynamics, and chemistry induce the logic of biological evolution
por: Pross, Addy, et al.
Publicado: (2017)

How to Respond to Misinformation From the Anti-Vaccine Movement
por: Westhoff, Mike-Andrew, et al.
Publicado: (2023)

Editorial: Therapeutic targeting of splicing variants in cancer
por: Sarvari, Pouya, et al.
Publicado: (2023)

DNA methylation regulates expression of VEGF-R2 (KDR) and VEGF-R3 (FLT4)
por: Quentmeier, Hilmar, et al.
Publicado: (2012)

Alternatively spliced VEGF receptor-2 is an essential endogenous inhibitor of lymphatic vessels
por: Albuquerque, Romulo J.C., et al.
Publicado: (2009)

Identification of an exonic splicing silencer in exon 6A of the human VEGF gene
por: Wang, Rui, et al.
Publicado: (2009)

Stability and Species Specificity of Renal VEGF-A Splicing Patterns in Kidney Disease
por: Turner, R. J., et al.
Publicado: (2016)

Functional Implications of Novel Human Acid Sphingomyelinase Splice Variants
por: Rhein, Cosima, et al.
Publicado: (2012)

Xeroderma Pigmentosum: Gene Variants and Splice Variants
por: Martens, Marie Christine, et al.
Publicado: (2021)

How to Splice Engine Bands
por: Maxfield, George A.
Publicado: (1890)

Regulation of alternative VEGF-A mRNA splicing is a therapeutic target for analgesia()
por: Hulse, R.P., et al.
Publicado: (2014)

New Insights into VEGF-A Alternative Splicing: Key Regulatory Switching in the Pathological Process
por: Dehghanian, Fariba, et al.
Publicado: (2014)

Modulation of VEGF-A Alternative Splicing as a Novel Treatment in Chronic Kidney Disease
por: Stevens, Megan, et al.
Publicado: (2018)

Identification of splice defects due to noncanonical splice site or deep‐intronic variants in ABCA4
por: Fadaie, Zeinab, et al.
Publicado: (2019)

Analysis of VEGFA Variants and Changes in VEGF Levels Underscores the Contribution of VEGF to Polycystic Ovary Syndrome
por: Almawi, Wassim Y, et al.
Publicado: (2016)

PRO B: evaluating the effect of an alarm-based patient-reported outcome monitoring compared with usual care in metastatic breast cancer patients—study protocol for a randomised controlled trial
por: Karsten, Maria Margarete, et al.
Publicado: (2021)

Performance Evaluation of SpliceAI for the Prediction of Splicing of NF1 Variants
por: Ha, Changhee, et al.
Publicado: (2021)

NeoSplice: a bioinformatics method for prediction of splice variant neoantigens
por: Chai, Shengjie, et al.
Publicado: (2022)

SpliceVault predicts the precise nature of variant-associated mis-splicing
por: Dawes, Ruebena, et al.
Publicado: (2023)

High EVI1 and PARP1 expression as favourable prognostic markers in high-grade serous ovarian carcinoma
por: Jank, Paul, et al.
Publicado: (2023)

The VEGF-A exon 8 splicing-sensitive fluorescent reporter mouse is a novel tool to assess the effects of splicing regulatory compounds in vivo
por: Stevens, M., et al.
Publicado: (2019)

A drug-repositioning screen using splicing-sensitive fluorescent reporters identifies novel modulators of VEGF-A splicing with anti-angiogenic properties
por: Star, Eleanor, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_65ihuagm0cnlsdqikdk3v22r32